BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 19455418)

  • 1. Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer.
    Karn T; Metzler D; Ruckhäberle E; Hanker L; Gätje R; Solbach C; Ahr A; Schmidt M; Holtrich U; Kaufmann M; Rody A
    Breast Cancer Res Treat; 2010 Apr; 120(3):567-79. PubMed ID: 19455418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning for RNA sequencing-based intrinsic subtyping of breast cancer.
    Cascianelli S; Molineris I; Isella C; Masseroli M; Medico E
    Sci Rep; 2020 Aug; 10(1):14071. PubMed ID: 32826944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy.
    Zhang W; Li E; Wang L; Lehmann BD; Chen XS
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular differences between younger versus older ER-positive and HER2-negative breast cancers.
    Qing T; Karn T; Rozenblit M; Foldi J; Marczyk M; Shan NL; Blenman K; Holtrich U; Kalinsky K; Meric-Bernstam F; Pusztai L
    NPJ Breast Cancer; 2022 Nov; 8(1):119. PubMed ID: 36344517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Directed Random Walk for the Identification of Breast Cancer Prognostic Markers from Multiclass Expression Data.
    Nies HW; Mohamad MS; Zakaria Z; Chan WH; Remli MA; Nies YH
    Entropy (Basel); 2021 Sep; 23(9):. PubMed ID: 34573857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer.
    Bacci M; Lorito N; Ippolito L; Ramazzotti M; Luti S; Romagnoli S; Parri M; Bianchini F; Cappellesso F; Virga F; Gao Q; Simões BM; Marangoni E; Martin LA; Comito G; Ferracin M; Giannoni E; Mazzone M; Chiarugi P; Morandi A
    Cell Rep; 2019 Jul; 28(1):104-118.e8. PubMed ID: 31269432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of α- and β2-adrenoceptor gene expression in breast cancer patients.
    Rivero EM; Martinez LM; Bruque CD; Gargiulo L; Bruzzone A; Lüthy IA
    Br J Clin Pharmacol; 2019 Sep; 85(9):2143-2154. PubMed ID: 31218733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parsimonious Gene Correlation Network Analysis (PGCNA): a tool to define modular gene co-expression for refined molecular stratification in cancer.
    Care MA; Westhead DR; Tooze RM
    NPJ Syst Biol Appl; 2019; 5():13. PubMed ID: 30993001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of Tumor Infiltrating Lymphocytes after Core Needle Biopsy and the Prognostic Implications in Early Stage Breast Cancer: A Retrospective Study.
    Huang J; Chen X; Fei X; Huang O; Wu J; Zhu L; He J; Chen W; Li Y; Shen K
    Cancer Res Treat; 2019 Oct; 51(4):1336-1346. PubMed ID: 30744321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of nomograms integrating immune-related genomic signatures with clinicopathologic features to improve prognosis and predictive value of triple-negative breast cancer: A gene expression-based retrospective study.
    Wang K; Li HL; Xiong YF; Shi Y; Li ZY; Li J; Zhang X; Li HY
    Cancer Med; 2019 Feb; 8(2):686-700. PubMed ID: 30677255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of the Unfolded Protein Response in Breast Cancer Subtypes.
    Jiang D; Turner B; Song J; Li R; Diehn M; Le QT; Khatri P; Koong AC
    JCO Precis Oncol; 2017; 2017():. PubMed ID: 29888341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α-XBP1 Activation.
    Yang Z; Zhang J; Jiang D; Khatri P; Solow-Cordero DE; Toesca DAS; Koumenis C; Denko NC; Giaccia AJ; Le QT; Koong AC
    Mol Cancer Res; 2018 May; 16(5):745-753. PubMed ID: 29440447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy.
    Qian J; Chen H; Ji X; Eisenberg R; Chakravarthy AB; Mayer IA; Massion PP
    Sci Rep; 2017 Apr; 7():45828. PubMed ID: 28387221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer.
    Karn T; Rody A; Müller V; Schmidt M; Becker S; Holtrich U; Pusztai L
    Genom Data; 2014 Dec; 2():354-6. PubMed ID: 26484129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer.
    Witzel I; Milde-Langosch K; Schmidt M; Karn T; Becker S; Wirtz R; Rody A; Laakmann E; Schütze D; Jänicke F; Müller V
    Onco Targets Ther; 2014; 7():2205-13. PubMed ID: 25506225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer.
    Sänger N; Ruckhäberle E; Györffy B; Engels K; Heinrich T; Fehm T; Graf A; Holtrich U; Becker S; Karn T
    Mol Oncol; 2015 Jan; 9(1):58-67. PubMed ID: 25131496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer.
    Sänger N; Ruckhäberle E; Bianchini G; Heinrich T; Milde-Langosch K; Müller V; Rody A; Solomayer EF; Fehm T; Holtrich U; Becker S; Karn T
    Mol Oncol; 2014 Oct; 8(7):1196-207. PubMed ID: 24785095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent gene signatures for han chinese breast cancers.
    Huang CC; Tu SH; Lien HH; Jeng JY; Huang CS; Huang CJ; Lai LC; Chuang EY
    PLoS One; 2013; 8(10):e76421. PubMed ID: 24098497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer.
    Chen X; Sun L; Mao Y; Zhu S; Wu J; Huang O; Li Y; Chen W; Wang J; Yuan Y; Fei X; Jin X; Shen K
    BMC Cancer; 2013 Aug; 13():390. PubMed ID: 23957561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers.
    Witzel I; Graeser M; Karn T; Schmidt M; Wirtz R; Schütze D; Rausch A; Jänicke F; Milde-Langosch K; Müller V
    J Cancer Res Clin Oncol; 2013 May; 139(5):809-16. PubMed ID: 23392859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.